NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
DICE Therapeutics, Inc. Common Stock (NASDAQ: DICE)
DICE Technical Analysis
4
As on 9th Jun 2023 DICE STOCK Price closed @ 32.96 and we RECOMMEND Buy for LONG-TERM with Stoploss of 20.46 & Strong Buy for SHORT-TERM with Stoploss of 18.67 we also expect STOCK to react on Following IMPORTANT LEVELS. |
DICESTOCK Price
Open | 32.61 | Change | Price | % |
High | 33.08 | 1 Day | 0.38 | 1.17 |
Low | 32.00 | 1 Week | 1.35 | 4.27 |
Close | 32.96 | 1 Month | 0.08 | 0.24 |
Volume | 321256 | 1 Year | 9.54 | 40.73 |
52 Week High 42.23 | 52 Week Low 13.19 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
DICE Daily Charts |
DICE Intraday Charts |
Whats New @ Bazaartrend |
DICE Free Analysis |
|
DICE Important Levels Intraday
RESISTANCE | 35.04 |
RESISTANCE | 34.37 |
RESISTANCE | 33.96 |
RESISTANCE | 33.55 |
SUPPORT | 32.37 |
SUPPORT | 31.96 |
SUPPORT | 31.55 |
SUPPORT | 30.88 |
DICE Forecast May 2024
4th UP Forecast | 50.01 |
3rd UP Forecast | 44.54 |
2nd UP Forecast | 41.16 |
1st UP Forecast | 37.78 |
1st DOWN Forecast | 28.14 |
2nd DOWN Forecast | 24.76 |
3rd DOWN Forecast | 21.38 |
4th DOWN Forecast | 15.91 |
DICE Weekly Forecast
4th UP Forecast | 40.34 |
3rd UP Forecast | 37.97 |
2nd UP Forecast | 36.51 |
1st UP Forecast | 35.05 |
1st DOWN Forecast | 30.87 |
2nd DOWN Forecast | 29.41 |
3rd DOWN Forecast | 27.95 |
4th DOWN Forecast | 25.58 |
DICE Forecast2024
4th UP Forecast | 97.24 |
3rd UP Forecast | 76.63 |
2nd UP Forecast | 63.88 |
1st UP Forecast | 51.14 |
1st DOWN Forecast | 14.78 |
2nd DOWN Forecast | 2.04 |
3rd DOWN Forecast | -10.71 |
4th DOWN Forecast | -31.32 |
DICE Therapeutics, Inc. Common Stock ( NASDAQ USA Symbol : DICE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
DICE Other Details
Segment | EQ | |
Market Capital | 1163373952.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
DICE Address
DICE Latest News
DICE Business Profile
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lead therapeutic candidate is S011806, an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17, which is a validated drug target implicated in a various immunology indications. It is also developing oral therapeutic candidates targeting a4ß7 integrin for the treatment of inflammatory bowel diseases, as well as targeting aVß1/aVß6 integrin for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2013 and is headquartered in South San Francisco, California. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service